Riskpilot← Back to searchSign inGet full accessBiotest Facility ApS
APSActiveCVR 37974382Røvedvej 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 201619 employeeswww.biotestfacility.com
Revenue 2024
DKK 4,5M
+57% vs 2023
EBITDA margin
14.2%
+55% vs 2023
Equity ratio
28.1%
Financial strength
Net profit 2024
DKK 339K
+45% vs 2023
| Revenue | DKK 4,5M | +57% |
| EBITDA | DKK 643K | +55% |
| Net profit | DKK 339K | +45% |
| Total assets | DKK 1,7M | +35% |
| Equity | DKK 492K | +221% |
| Employees | 19 | — |
Legal name
Biotest Facility ApS
CVR number
37974382
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29. august 2016
Share capital
DKK 100.000
Employees
19 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør
Company purpose
Selskabets formål er kontraktforskning, laboratoriemæssig service og handel med knowhow og laboratorieydelser
Address
Røvedvej 1
Phone
+4528192682
Email
mkruhoffer@biotestfacility.com
Website
www.biotestfacility.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 923 | 1.229 | 1.897 | 1.861 | 1.694 | 1.179 | 2.870 | 4.518 |
| Staff expenses | -760 | -939 | -1.564 | -1.682 | -1.644 | -1.555 | -2.455 | -3.875 |
| EBITDA | 164 | 290 | 333 | 179 | 50 | -376 | 415 | 643 |
| Depreciation & amort. | -92 | -92 | -98 | -109 | -107 | -98 | -81 | -174 |
| EBIT | 71 | 198 | 235 | 70 | -57 | -474 | 334 | 469 |
| Net financials | -53 | -43 | -44 | -48 | -38 | -33 | -42 | -34 |
| Profit before tax | 18 | 155 | 191 | 22 | -95 | -507 | 292 | 435 |
| Tax | 10 | 35 | 42 | 5 | -21 | -105 | 58 | 96 |
| Net profit | 8 | 121 | 149 | 17 | -74 | -402 | 234 | 339 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1.180 | 1.325 | 1.627 | 1.712 | 1.392 | 781 | 1.292 | 1.749 |
| Equity | 108 | 229 | 378 | 395 | 321 | -81 | 153 | 492 |
| Long-term debt | 850 | 772 | 806 | 643 | 569 | 472 | 276 | 200 |
| Short-term debt | 134 | 239 | 364 | 606 | 456 | 352 | 837 | 1.000 |
| Total debt | 984 | 1.012 | 1.169 | 1.250 | 1.024 | 824 | 1.113 | 1.200 |
EBITDA margin
14.2%
This company
15.8%
Market median
-10% vs market
20172024
Equity ratio
28.1%
This company
38.2%
Market median
-26% vs market
20172024
Return on equity
68.9%
This company
18.4%
Market median
+274% vs market
20172024
Net profit margin
7.5%
This company
8.1%
Market median
-7% vs market
20172024
Asset turnover
2.58×
This company
1.12×
Market median
+130% vs market
20172024
Debt / equity
2.55×
This company
0.62×
Market median
-311% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2016-08-29 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CL Management | Management | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2016 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HMK CONSULT ApS | Company | 100.0% | 100.0% | 2024 |
BioXpedia A/S | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HMK CONSULT ApS
Biotest Facility ApS Board members of Biotest Facility ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carsten Leander Buus | Management | 0 companies |
| Nicolai Enevold Hansen | Chairman | 0 companies |
| Agnete Lystlund Vestergaard | Board of Directors | 0 companies |
| Mogens Kruhøffer | Chairman | 0 companies |